513 related articles for article (PubMed ID: 10458827)
21. Salivary gland basal cell and canalicular adenomas: immunohistochemical demonstration of myoepithelial cell participation and morphogenetic considerations.
Zarbo RJ; Prasad AR; Regezi JA; Gown AM; Savera AT
Arch Pathol Lab Med; 2000 Mar; 124(3):401-5. PubMed ID: 10705394
[TBL] [Abstract][Full Text] [Related]
22. SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis.
Ohtomo R; Mori T; Shibata S; Tsuta K; Maeshima AM; Akazawa C; Watabe Y; Honda K; Yamada T; Yoshimoto S; Asai M; Okano H; Kanai Y; Tsuda H
Mod Pathol; 2013 Aug; 26(8):1041-50. PubMed ID: 23558573
[TBL] [Abstract][Full Text] [Related]
23. Epithelial membrane antigen and DOG1 expression in minor salivary gland tumours.
Andrade EP; Teixeira LN; Montalli VAM; Garcia FM; Passador-Santos F; Soares AB; Araújo VC
Ann Diagn Pathol; 2019 Dec; 43():151408. PubMed ID: 31629156
[TBL] [Abstract][Full Text] [Related]
24. Hierarchical cluster analysis of myoepithelial/basal cell markers in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma.
Prasad ML; Barbacioru CC; Rawal YB; Husein O; Wen P
Mod Pathol; 2008 Feb; 21(2):105-14. PubMed ID: 18084258
[TBL] [Abstract][Full Text] [Related]
25. Salivary gland epithelial neoplasms in pediatric population: a single-institute experience with a focus on the histologic spectrum and clinical outcome.
Xu B; Aneja A; Ghossein R; Katabi N
Hum Pathol; 2017 Sep; 67():37-44. PubMed ID: 28739497
[TBL] [Abstract][Full Text] [Related]
26. WT1 expression in salivary gland pleomorphic adenomas: a reliable marker of the neoplastic myoepithelium.
Langman G; Andrews CL; Weissferdt A
Mod Pathol; 2011 Feb; 24(2):168-74. PubMed ID: 21057459
[TBL] [Abstract][Full Text] [Related]
27. Correlation of human Bub1 expression with tumor-proliferating activity in salivary gland tumors.
Shigeishi H; Yoneda S; Taki M; Nobumori T; Ohta K; Higashikawa K; Yasui W; Kamata N
Oncol Rep; 2006 Apr; 15(4):933-8. PubMed ID: 16525682
[TBL] [Abstract][Full Text] [Related]
28. Beta-catenin and E-cadherin expression in salivary gland tumors.
Furuse C; Cury PR; Altemani A; dos Santos Pinto D; de Araújo NS; de Araújo VC
Int J Surg Pathol; 2006 Jul; 14(3):212-7. PubMed ID: 16959701
[TBL] [Abstract][Full Text] [Related]
29. Pleomorphic adenomas, adenoid cystic carcinomas and adenolymphomas of salivary glands analysed by a monoclonal antibody against myoepithelial/basal cells. An immunohistochemical study.
Caselitz J; Osborn M; Hamper K; Wustrow J; Rauchfuss A; Weber K
Virchows Arch A Pathol Anat Histopathol; 1986; 409(6):805-16. PubMed ID: 2429435
[TBL] [Abstract][Full Text] [Related]
30. Polymorphous low grade adenocarcinoma has a consistent p63+/p40- immunophenotype that helps distinguish it from adenoid cystic carcinoma and cellular pleomorphic adenoma.
Rooper L; Sharma R; Bishop JA
Head Neck Pathol; 2015 Mar; 9(1):79-84. PubMed ID: 24969705
[TBL] [Abstract][Full Text] [Related]
31. Myoepithelial cell markers in salivary gland neoplasms.
Furuse C; Sousa SO; Nunes FD; Magalhães MH; Araújo VC
Int J Surg Pathol; 2005 Jan; 13(1):57-65. PubMed ID: 15735856
[TBL] [Abstract][Full Text] [Related]
32. Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma.
Patel KR; Solomon IH; El-Mofty SK; Lewis JS; Chernock RD
Hum Pathol; 2013 Nov; 44(11):2501-8. PubMed ID: 24029710
[TBL] [Abstract][Full Text] [Related]
33. Morphological heterogeneity of oral salivary gland carcinomas: a clinicopathologic study of 41 cases with long term follow-up emphasizing the overlapping spectrum of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma.
Schwarz S; Müller M; Ettl T; Stockmann P; Zenk J; Agaimy A
Int J Clin Exp Pathol; 2011 Apr; 4(4):336-48. PubMed ID: 21577319
[TBL] [Abstract][Full Text] [Related]
34. DOG1: a novel marker of salivary acinar and intercalated duct differentiation.
Chênevert J; Duvvuri U; Chiosea S; Dacic S; Cieply K; Kim J; Shiwarski D; Seethala RR
Mod Pathol; 2012 Jul; 25(7):919-29. PubMed ID: 22460810
[TBL] [Abstract][Full Text] [Related]
35. 99mTcO4- accumulation in scintigraphy and expression of Na+/I- symporter in salivary gland tumors.
Akai A; Yamamura Y; Nonaka M; Yoshihara T
Auris Nasus Larynx; 2014 Dec; 41(6):532-8. PubMed ID: 25199743
[TBL] [Abstract][Full Text] [Related]
36. Twist Expression in Pleomorphic Adenoma, Adenoid Cystic Carcinoma and Mucoepidermoid Carcinoma of Salivary Glands.
Pardis S; Zare R; Jaafari-Ashkavandi Z; Ashraf MJ; Khademi B
Turk Patoloji Derg; 2016; 32(1):15-21. PubMed ID: 26832177
[TBL] [Abstract][Full Text] [Related]
37. The expression of alpha vascular smooth-muscle actin in salivary gland tumors.
Hirano T; Gluckman JL; deVries EJ
Arch Otolaryngol Head Neck Surg; 1990 Jun; 116(6):692-6. PubMed ID: 1692711
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of p63 isotypes (DeltaN and TA) in salivary gland neoplasms: biological and diagnostic implications.
Maruya S; Kies MS; Williams M; Myers JN; Weber RS; Batsakis JG; El-Naggar AK
Hum Pathol; 2005 Jul; 36(7):821-7. PubMed ID: 16084953
[TBL] [Abstract][Full Text] [Related]
39. Squamous/epidermoid differentiation in normal breast and salivary gland tissues and their corresponding tumors originate from p63/K5/14-positive progenitor cells.
Boecker W; Stenman G; Loening T; Andersson MK; Berg T; Lange A; Bankfalvi A; Samoilova V; Tiemann K; Buchwalow I
Virchows Arch; 2015 Jan; 466(1):21-36. PubMed ID: 25344874
[TBL] [Abstract][Full Text] [Related]
40. Analysis of histologic follow-up and risk of malignancy for salivary gland neoplasm of uncertain malignant potential proposed by the Milan System for Reporting Salivary Gland Cytopathology.
Liu H; Ljungren C; Lin F; Zarka MA; Chen L
Cancer Cytopathol; 2018 Jul; 126(7):490-497. PubMed ID: 29669190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
